What is Daratumumab?
Category: Prescription Drugs
Most popular types: Darzalex
See also: Daratumumab-bortezomib-dexamethasone Daratumumab-lenalidomide-dexamethasone (DRd)
Daratumumab is a monoclonal antibody used in treatment for individuals with multiple myeloma.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple myeloma | 24 | 11 | |
| Amlyoidosis | 1 | 1 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 2 | |
| Mild | 6 | |
| None | 2 |
Why patients stopped taking Daratumumab
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Side effects too severe | 1 |
Duration
Stopped taking Daratumumab
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 1 |
What people switch to and from
Patients started taking Daratumumab after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Carfilzomib (Kyprolis) | 6 | |
| Lenalidomide (Revlimid) | 3 | |
| Bortezomib (Velcade) | 2 | |
| Ixazomib (Ninlaro) | 2 | |
| Cyclophosphamide (Cytoxan) | 1 |
Patients stopped taking Daratumumab and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Elotuzumab (Empliciti) | 1 |
Last updated: